CaSR antagonists

Details for Australian Patent Application No. 2004232604 (hide)

Owner Japan Tobacco Inc.

Inventors Inoue, Teruhiko; Shindo, Masanori; Fukuda, Kenji; Shinagawa, Yuko; Kenogami, Taku; Kiguchi, Toshihiro; Nakagawa, Takashi; Soejima, Yuki; Ogawa, Naoki

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004232604

PCT Pub. Number WO2004/094362

Priority 2003-119131 23.04.03 JP

Filing date 23 April 2004

Wipo publication date 4 November 2004

Acceptance publication date 13 September 2007

International Classifications

C07C 217/28 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

A61P 3/14 (2006.01) Drugs for disorders of the metabolism

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 317/44 (2006.01) Sulfones

C07C 323/62 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07D 215/12 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 295/155 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/79 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

28 July 2005 PCT application entered the National Phase

  PCT publication WO2004/094362 Priority application(s): WO2004/094362

11 August 2005 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Japan Tobacco Inc., Application No. 2004232604, under INID (54) correct the title to read CaSR antagonist.

13 September 2007 Application Accepted

  Published as AU-B-2004232604

13 December 2007 Corrigenda

  Applications Accepted - Name Index Under the name Japan Tobacco Inc., Application No. 2004232604, under INID (72) correct the co-inventor name to read Ikenogami, Taku

3 January 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 30 Nov 2007. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000 2005

24 January 2008 Standard Patent Sealed

5 June 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 30 Nov 2007

11 June 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 06 Nov 2008. Address for service in Australia - Phillips Ormonde Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000

29 October 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Nov 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232605-Processes for producing pyrazoloacridone derivative and intermediate therefor

2004232577-Five-membered heterocyclic derivative